Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Romand

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The European Respiratory Journal|February 28, 2002
Management of lower respiratory tract infections by French general practitioners: the AIR II study. Analyse Infections RespiratoiresC Raherison, P Peray, R Poirier, et al.
Respiratory Medicine|September 26, 2003
Lower respiratory tract infections in adults: non-antibiotic prescriptions by GPsC Raherison, R Poirier, J P Daurès, et al.
Revue Des Maladies Respiratoires|January 1, 1990
[Can oximetry contribute to the detection of apnea? The use of a mathematical analysis of the oximetry signal]J L Pepin, P Levy, B Lepaulle, et al.
The European Respiratory Journal|March 1, 1991
Changes in left ventricular ejection fraction during REM sleep and exercise in chronic obstructive pulmonary disease and sleep apnoea syndromeP A Levy, C Guilleminault, D Fagret, et al.
Revue De Pneumologie Clinique|April 27, 2016
[One-year survival improvement in lung cancer in France. Results of the prospective real life studies KBP-2000-CPHG and KBP-2010-CPHG]M Grivaux, B Duvert, P Ferrer-Lopez, et al.
Annales De Chirurgie|January 1, 1992
[Diffuse bronchomalacia after double lung transplantation. Thoughts apropos of a case]P Y Brichon, D Blin, M Noirclerc, et al.
Revue Des Maladies Respiratoires|June 27, 2001
[Management of lower respiratory tract infections by general practitioners in France]A Taytard, J P Daures, P Arsac, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 14, 2026
Four-Year outcomes of first-line Nivolumab plus ipilimumab for 6 months versus continuation in patients with advanced non-small-cell lung cancer Results of the randomized IFCT-1701 "DICIPLE" Phase III trialG Zalcman, A Madroszyk, E Guenzi, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The European Respiratory Journal|February 28, 2002
Management of lower respiratory tract infections by French general practitioners: the AIR II study. Analyse Infections RespiratoiresC Raherison, P Peray, R Poirier, et al.
Respiratory Medicine|September 26, 2003
Lower respiratory tract infections in adults: non-antibiotic prescriptions by GPsC Raherison, R Poirier, J P Daurès, et al.
Revue Des Maladies Respiratoires|January 1, 1990
[Can oximetry contribute to the detection of apnea? The use of a mathematical analysis of the oximetry signal]J L Pepin, P Levy, B Lepaulle, et al.
The European Respiratory Journal|March 1, 1991
Changes in left ventricular ejection fraction during REM sleep and exercise in chronic obstructive pulmonary disease and sleep apnoea syndromeP A Levy, C Guilleminault, D Fagret, et al.
Revue De Pneumologie Clinique|April 27, 2016
[One-year survival improvement in lung cancer in France. Results of the prospective real life studies KBP-2000-CPHG and KBP-2010-CPHG]M Grivaux, B Duvert, P Ferrer-Lopez, et al.
Annales De Chirurgie|January 1, 1992
[Diffuse bronchomalacia after double lung transplantation. Thoughts apropos of a case]P Y Brichon, D Blin, M Noirclerc, et al.
Revue Des Maladies Respiratoires|June 27, 2001
[Management of lower respiratory tract infections by general practitioners in France]A Taytard, J P Daures, P Arsac, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 14, 2026
Four-Year outcomes of first-line Nivolumab plus ipilimumab for 6 months versus continuation in patients with advanced non-small-cell lung cancer Results of the randomized IFCT-1701 "DICIPLE" Phase III trialG Zalcman, A Madroszyk, E Guenzi, et al.
Pageof 2